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Modifications of plasma proteins, structural proteins and other ma-
cromolecules by glycation (the Maillard reaction) contribute to the
development of accelerated atherosclerosis and other complications
in diabetes and are also involved in the pathogenesis of aging. Mo-
nosaccharide esters, which mimic the reactivity of sugar 6-phospha-
te esters in nonenzymatic glycations, were prepared from endogenous
opioid peptide leucine-enkephalin (Tyr-Gly-Gly-Phe-Leu), smaller
peptides of different lengths (Tyr-Pro-Phe-Val, Tyr-Pro-Phe, Tyr-Pro)
and from only one amino acid (Tyr) and were used as model com-
pounds for a study of the Maillard reaction in vitro. It was found
that these compounds readily undergo intramolecular reactions
leading to different types of products, such as Amadori compounds,
imidazolidinones, glycosylamine, diketopiperazine, pyrrololactone,
etc. The obtained results demonstrate that the chemical properties
of the glycopeptides studied are determined by the structure and
length of the peptide chain, suggesting that similar products may
be also generated in the early stages of the Maillard reaction in vivo.
Key words: glycopeptides, enkephalin, opioid, imidazolidinone, Mail-
lard, glycation.
INTRODUCTION
Undesirable pharmaceutical and biopharmaceutical properties often
hinder clinical development of biologically active compounds. One approach
that has been used to improve the physicochemical properties is preparation
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of ester prodrugs. Recent investigations have revealed that glycoconjugates
possessing an ester bond between the bioactive moiety and one of the sugar
hydroxyls are valuable new tools in biomedical research. These monosaccha-
ride esters seem to be able to improve antiviral1,2 and antibacterial activity,3
increase the intestinal permeability,4 alter receptor-selectivity,5 or they may
be used as monomers in polycondensation reactions6 as well as building
blocks for the solid phase combinatorial synthesis of libraries of novel glyco-
peptides7 and in peptide templated glycosylation reactions.8
In our approach, structurally well-defined monosaccharide esters of pep-
tides have been used for the first time to study the biological phenomena as-
sociated with the complex reaction occurring in every living organism,
known as the Maillard reaction. In this reaction, reducing sugars, such as
glucose, can react nonenzymatically with proteins, glycoproteins, lipids and
nucleic acids to produce a variety of carbohydrate adducts known as advan-
ced glycation end products (AGEs).9,10 It is generally accepted that in the
early stage of the Maillard reaction, sugars react with the amino groups of
proteins to form keto-sugar derivatives or Amadori rearrangement products
via Schiff bases. In the advanced stage, many different complex reactions
occur leading to AGE products associated with diabetic complications,11 ag-
ing,12 vascular diseases,13 chronic renal failure,14 and Alzheimer's disease.15
Although the occurrence of the Maillard reaction with a variety of proteins
has been demonstrated, the reactivity of individual sugar and peptide com-
ponents as well as the sequence of reactions that Amadori compounds un-
dergo to generate AGEs are still poorly understood.
In order to gain a better insight into the mechanisms and products of
the Maillard reaction, we have used the sugar-peptide esters in which dif-
ferent monosaccharide moieties are linked through their C-6 hydroxy
groups to the C-terminal carboxy group of the endogenous opioid pentapep-
tide leucine-enkephalin as well as to some other small peptides.5,16 We as-
sumed that such carbohydrate esters represent an ideal model system for
the study of the Maillard reaction in vitro since these molecules contain a
free amino group at the N-terminus of the peptide moiety as well as the
reducing sugar moiety. They will mimic the reactivity of the sugar 6-phos-
phate esters in the glycation reactions, and for steric reasons, the attached
peptide is more likely to form carbohydrate-peptide adducts than the parent
saccharide alone.
We have also examined the reactivity of monosaccharide esters in which
glucose is linked to amino acid residues as models for teichoic acid frag-
ment.17 It occurred to us that the ability of Gram-positive strains to stimu-
late the production of pro-inflammatory cytokines, which may be important
in the pathogenesis of shock caused by these bacteria,18 reveals some strik-
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ing similarities with the effects caused by AGE products, capable of trigger-
ing cellular processes linked to accelerated vascular and inflammatory com-
plications.19 Since diverse physiological functions of Gram-positive bacteria
are controlled by the degree of esterification of teichoic acids with D-alani-
ne,20 one of our goals was to examine on the model compounds whether, in
Gram-positive pathogens, reactivity of the free amino group of D-alanine es-
ters in teichoic acid could be responsible for producing specific AGE-like
compounds, which would have a direct impact on inflammatory processes.
In this paper we will attempt to give an overview of our recent results
and provide some new insights into the Maillard reaction mechanisms, ob-
tained by using monosaccharide esters of peptides and amino acids as inves-
tigation tools. All compounds mentioned in this article were purified using
RP HPLC and fully characterized structurally by elemental analysis, NMR
and MS spectroscopy.
INTRAMOLECULAR REACTIONS OF SUGAR-PEPTIDE ESTERS
RELATED TO LEUCINE-ENKEPHALIN
In our previous studies we have demonstrated5 that introduction of sac-
charides into leucine-enkephalin (Tyr-Gly-Gly-Phe-Leu), belonging to the
class of important endogenous neuropeptides,21 has a modifying influence
on the biological activity profile of the parent peptide compound. Thus, eval-
uation of the opioid activities in the guinea pig ileum and mouse vas de-
ferens assays of the D-gluco- (1), D-manno- (2) and D-galacto-ester (3) of
leucine-enkephalin, illustrated in Figure 1, revealed that introducing differ-
ent monosaccharide moieties at the C-terminal position of the pentapeptide
changes the opioid activity profile and results in an enhanced interaction
with the -opioid receptor.5 Monosaccharide esters 1–3 were used as model
compounds for the study of the Maillard reaction.
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Figure 1. Structure of the monosaccharide esters of leucine-enkephalin 1–3.
As the Amadori rearrangement is known to be a complex acid-base cata-
lyzed reaction in which the balance of the acidity and basicity in the reac-
tion system controls the simultaneous and consecutive reactions,22 pyridi-
ne-acetic acid was used as an ideal solvent for the study of the Amadori
product formation. When dissolved in this solvent and incubated at ambient
temperature for 24 h, esters 1 and 2 were readily transformed to the
D-fructofuranose-related bicyclic Amadori product 4 in 58 and 50% yield, re-
spectively, whereas D-galactose ester 3 incubated at 4 oC for 24 h afforded
D-tagatofuranose-related compound 5 (Figure 2) in 20% yield.23 Hydrolysis
of compounds 4 and 5 resulted in N-(1-deoxy-D-fructos-1-yl) (6) and N-(1-
deoxy-D-tagatos-1-yl) (7) Amadori products of leucine-enkephalin, indistin-
guishable from 6 and 7 obtained by different reaction methods.
It appears that the formation of bicyclic products 4 and 5 from mono-
saccharide esters 1–3 is favoured compared to the Amadori product 6 and 7
formation from their parent sugars (glucose, mannose, galactose) and leuci-
ne-enkephalin. The esterified carboxy group of the pentapeptide does not
account per se for the increased reactivity of compounds 1–3 since leuci-
ne-enkephalin methyl ester, incubated with D-glucose under identical condi-
tions, showed similar reactivity as the carboxy unprotected peptide. In fact,
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Figure 2. Amadori rearrangement products of monosaccharide esters 1–3.
the behaviour of esters 1–3 closely resembled that found for D-glucose
6-phosphate, which reacted considerably faster with amines than did D-glu-
cose itself.24 Since formation of the Amadori compounds requires the
open-chain form of the reducing sugar, it can be assumed that, similarly to
D-glucose 6-phosphate, the acyclic forms of compounds 1–3 are either more
abundant in solution or more efficiently trapped, whereafter the equilibria
producing the acyclic forms are rapidly restored.
In contrast to this study, we provided evidence that intramolecular cycli-
zation of leucine-enkephalin monosaccharide esters 1–3, in methanol as the
solvent, resulted in the formation of novel glycation products in the Mail-
lard reaction having imidazolidinone ring in the molecule (compounds 8–10)
(Figure 3).25–27 Considering the mechanism of the formation of imidazolidi-
ESTER-LINKED GLYCOPEPTIDES 791
MeOH
1-3
R1
N
CH
NH
O OH
HN
O
HN
O
NH
O
O
O
CH
2
NaOH
N
CH
NH
O OH
HN
O
HN
O
NH
O
OH
O
R2
8-10 11-13
HO
8 9 10
R1
OH
OH
OH
OH
OH
OH
OH
HOHO HO
HO
11 12 13
CH2OH CH2OHCH2OH
R2
OH
OH
OH
OH
OH
OH
OH
HO
HOHO
HO
HO
Figure 3. Formation of imidazolidinones from esters 1–3.
nones 8–10, in the first step, similarly to the formation of Amadori products
4 and 5 from esters 1–3, the aldehyde group of the open-chain form of the
carbohydrate moiety is attacked by the free amino terminus of the peptide
moiety and the cyclic Schiff base 14 is formed as an intermediate (Figure 4).
In the subsequent step, the Schiff base, instead of Amadori rearrangement
to the corresponding keto-sugars 4 and 5, undergoes nucleophilic attack by
the Gly2 nitrogen to yield imidazolidinones 8–10 in which C-1 of the sugar
moiety forms a bridge between the amino group of the N-terminal tyrosine
residue and the amide nitrogen of the Tyr1-Gly2 peptide bond. Transforma-
tion of mannose ester 2 to imidazolidinone 9 took place completely stereo-
specifically,26 while the conversion of glucose ester 1 and galactose ester 3 to
the corresponding derivatives 8 and 10, respectively, resulted in the forma-
tion of imidazolidinone diastereoisomers having cis or trans relative geome-
try of the substituents at the imidazolidinone ring moiety.27
Cleavage of ester bonds in both the major and minor isomers of com-
pounds 8–10 led to the corresponding D-gluco- (11), D-manno- (12) and D-
galacto-related (13) imidazolidinones (Figure 3) in 77–96% yields.
It is important that this study demonstrated for the first time, by in vi-
tro experiments, that in addition to Amadori rearrangement, an alternative
pathway for carbohydrate-induced modification is possible. The experimen-
tal fact that monosaccharide esters 1–3, the behaviour of which closely re-
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Figure 4. Structure of the Schiff base 14.
sembles the reactivity of hexose 6-phosphates, yield either the correspond-
ing Amadori products or imidazolidinones, points to the possibility that,
depending on the physiological environment, adducts similar to imidazoli-
dinones 11–13 may be also generated in vivo by the reaction of hexose sug-
ars with the available amino groups on peptides and proteins.
EFFECTS OF THE PEPTIDE OR AMINO ACID MOIETY
ON THE PATHWAYS OF INTRAMOLECULAR REACTIONS
IN SUGAR ESTERS
The finding that enkephalin-related monosaccharide esters 1–3 in pyri-
dine-acetic acid readily undergo intramolecular reaction to Amadori com-
pounds raised the question whether the observed rearrangements are gen-
eral phenomena or depend upon the length and the amino acid sequence in
the peptide moiety of the sugar ester.
With the aim to examine the chemical reactivity of peptide and amino
acid monosaccharide esters, we have prepared conjugates 15–18 (Figure 5)
in which D-glucose is linked to Tyr-Pro-Phe-Val (15), Tyr-Pro-Phe (16), Tyr-Pro
(17), and to only one amino acid Tyr (18) by an ester bond involving hydroxy
group at C-6 of the D-glucopyranose moiety.16,17 The relation between the
structure and reactivity of glycoconjugates 15–18 has been studied in py-
ridine-acetic acid solvent system.
Incubation of tetrapeptide ester 15, whose amino acid sequence corre-
sponds to the 51–54 fragment of human -casein (found to possess weak
opioid activity),28 for 24 h at room temperature resulted in bicyclic keto-su-
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Figure 5. Structure of monosaccharide esters 15–18.
gar derivative 19 (Figure 6), an Amadori compound, in the -furanose form.16
In fact, the product of the intramolecular transformation of tetrapeptide es-
ter 15 was analogous to compound 4, obtained under identical reaction con-
ditions from monosaccharide ester 1.
In contrast, by heating tripeptide ester 16 in the same solvent system
for 24 h at 37 oC and at 50 oC, two different products were obtained. At 37
oC, by intramolecular cyclization of 16, the major product isolated in a 52%
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Figure 6. Products of intramolecular reactions of compounds 15–17.
yield was bicyclic -D-glucosylamine derivative 20 (Figure 6), whereas incu-
bation of 16 at a higher temperature (50 oC) gave cyclo-(Tyr-Pro) (21)
(68%).16 Formation of glucosylamine tripeptide derivative 20 was explained
by formation of a Schiff base as intermediate, which through intramolecular
reaction of the sugar C-5 hydroxy group with C-1 then closes to give hemi-
acetal 20. The fact that the incubation mixture of monosaccharide ester 16
at 37 oC contained, in addition to 20, only traces of diketopiperazine 21,
while incubation at 50 oC gave exclusively 21, suggested the bicyclic com-
pound 20 as the precursor of cyclo-(Tyr-Pro) 21. We speculated that at
higher temperatures, for steric reasons, the proline carbonyl atom in 20 is
more vulnerable to nucleophilic attack by the secondary NH group of the ty-
rosine residue, resulting in diketopiperazine 21 formation after cyclization
and cleavage of the easily hydrolyzed N-glucosyl-amino acid bond.29
It is generally accepted that the Amadori rearrangement, transforma-
tion of the Schiff bases, or their cyclic forms glycosylamines, into 1-amino-
1-deoxy-2-keto-sugar derivatives, readily occurs with N-glycosylamino ac-
ids.29 Surprisingly, attempts to rearrange glucosylamine tripeptide deriva-
tive 20 into the corresponding keto-sugar derivative were unsuccessful. Ho-
wever, heating of D-glucose with tripeptide Tyr-Pro-Phe at 37 oC for 2 days
in pyridine-acetic acid afforded the corresponding Amadori product N-(1-
deoxy-D-fructos-1-yl)-Tyr-Pro-Phe as the major product (26%) whereas no
glucosylamine derivative of the tripeptide was detected in the reaction mix-
ture.16 It is rational to presume that the inability of 20 to rearrange into the
keto-sugar derivative is due to conformational reasons, however, further
NMR and molecular modeling analyses were initiated to elucidate this as-
sumption.
When dipeptide ester 17 was dissolved in pyridine-acetic acid and kept
at 4 oC for 2 days, diketopiperazine 21 was the only product generated in
48% yield. Although it is known that diketopiperazine formation by intra-
molecular nucleophilic addition of the terminal amino group to the carbonyl
carbon of the second amino acid residue occurs easily in dipeptide esters be-
cause of good leaving groups (alcohol molecules),30 it is interesting that nei-
ther the corresponding glucosylamine derivative nor the Amadori product
were detected in the reaction mixture as a consequence of the intramolecu-
lar reaction between the sugar and dipeptide moiety in ester 17.
These results have evidenced that monosaccharide esters 15–17 easily
undergo intramolecular chemical transformations, subsequent to the attack
of the free N-terminal amino group on the peptide backbone or on the ano-
meric position of the D-glucose moiety. The data also indicate that the struc-
ture and the length of peptides direct the specific chemical reactions and the
products formed in the early stage of the Maillard reaction.
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Surprisingly, and in contrast to the results obtained with monosaccha-
ride esters of peptides, we have demonstrated17 that the tyrosine-related es-
ter 18, a model of teichoic acid fragment, due to the enhanced reactivity,
readily undergoes intramolecular reactions leading to a heterogeneous mix-
ture of compounds. As evidenced by RP HPLC, after 24 h of incubation in
pyridine-acetic acid, the abundance of degradation products exceeded 90%
in ester 18. From the numerous reaction products formed from 18 (Figure
7), it was possible to isolate pure pyrrololactone 22 (5%) as the major rear-
rangement product. Considering the formation of lactone 22 from monosac-
charide ester 18, we assume that in contrast to the intramolecular reactions
of esters 1–3 yielding stable bicyclic Amadori products 4 and 5 under identi-
cal reaction conditions, the unstable keto-sugar derivative formed from 18
rearranges by enolization and -elimination further to the reactive deoxy-
hexosone amino acid ester. For steric reasons, the nucleophilic attack of the
free amino group on the reactive hexosone carbonyl group is facilitated, re-
sulting, after dehydration, in lactone 22.17
In addition to lactone 22, from the reaction mixture of the starting com-
pound 18 it was possible to isolate, in less than 1% yield each, Amadori com-
pound 23, 4-hydroxyphenylacetic acid (24), 4-hydroxybenzaldehyde (25),
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4-hydroxybenzoic acid (26) and N-acetyl-tyrosine (27) (Figure 7), assumed to
arise from rearrangements and/or Strecker degradation of the initially for-
med intramolecular carbohydrate-amino acid adducts.
In order to gain better understanding of the effect imposed by esterifi-
cation of the amino acid with a carbohydrate moiety on the reactivity of the
amino group, ester 18 as well as tyrosine and glucose were incubated sepa-
rately in pyridine-acetic acid at 50 oC for 24 h. The relative amounts of la-
ctone 22 and compounds 24–27 determined in both reaction mixtures clear-
ly showed that the formation of these products from ester 18 is favoured in
comparison with the formation of the same compounds from D-glucose and
tyrosine.17
Taken together, we have demonstrated an activating effect of the sugar
substituent on the amino acid residue, resulting in a complex mixture of
products. Our findings also suggest that the carbohydrate esters of D-ala-
nine present in teichoic acids of Gram-positive bacteria could be considered
participants in molecular recognition processes by producing bioactive che-
mical messengers capable of altering the properties of the host cells.
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SA@ETAK
Esterski povezani glikopeptidi kao modeli za prou~avanje
biolo{kih pojava
[tefica Horvat, Ivanka Jeri}, Lidija Varga-Defterdarovi},
Maja Ro{~i} i Jaroslav Horvat
Glikacijom uzrokovane promjene plazmatskih proteina, strukturnih proteina i
ostalih makromolekula (Maillardova reakcija) pridonose razvoju ubrzane ateroskle-
roze i ostalih komplikacija kod dijabetesa, a tako|er su uklju~ene i u patogenezu sta-
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renja. Esteri monosaharida, koji po reaktivnosti sli~e 6-fosfatnim esterima {e}era,
pripravljeni su iz endogenog opioidnog peptida leucin-enkefalina (Tyr-Gly-Gly-Phe-
Leu), manjih peptida razli~ite duljine (Tyr-Pro-Phe-Val, Tyr-Pro-Phe, Tyr-Pro) i iz
samo jedne aminokiseline (Tyr) te su uporabljeni kao modelni spojevi za prou~avanje
Maillardove reakcije in vitro. Prona|eno je da ti spojevi lako podlije`u intramolekul-
skim reakcijama, pri ~emu nastaju razli~iti tipovi produkata, npr. Amadorijevi spo-
jevi, imidazolidinoni, glikozilamin, diketopiperazin, pirol-lakton itd. Dobiveni rezul-
tati jasno pokazuju da kemijska svojstva prou~avanih spojeva ovise o strukturi i
duljini peptidnog lanca i upu}uju na mogu}e nastajanje sli~nih produkata u ranom
stupnju Maillardove reakcije in vivo.
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